4.7 Article

Effect of Vitamin D Supplementation on Glycemic Control in Prediabetes: A Meta-Analysis

Journal

NUTRIENTS
Volume 13, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/nu13124464

Keywords

vitamin D; prediabetes; glycemic control; meta-analysis

Funding

  1. National Natural Science Foundation of China [81872626, 82003454]
  2. Chinese Nutrition Society-Bright Moon Seaweed Group Nutrition and Health Research Fund [CNS-BMSG2020A63]
  3. Chinese Nutrition Society-Zhendong National Physical Fitness and Health Research Fund [CNS-ZD2019066]
  4. Key R&D and Promotion Projects in Henan Province [212102310219]

Ask authors/readers for more resources

The clinical research results on vitamin D supplementation in improving prediabetes are controversial. However, this meta-analysis found that supplementing with vitamin D led to significant improvements in FBG, HbA1c, and FINS among prediabetics. Subgroup analysis showed that certain populations, such as those in Asia and individuals with vitamin D deficiency, may benefit more from long-term vitamin D supplementation in terms of glucose metabolism and insulin resistance.
Clinical research results of vitamin D supplementation in the improvement of prediabetes remain controversial. Accordingly, a literature search was conducted of PubMed, Embase (Ovid), and Web of Science prior to 9 November 2021. Randomized controlled studies reported that the following indicators were included: body mass index (BMI), fasting blood glucose (FBG), 2 h oral glucose tolerance test plasma glucose (2h-PG), hemoglobin A1c (HbA1c), insulin resistance by homeostasis model assessment (HOMA-IR), homeostasis model assessment of beta-cell function (HOMA-B), and fasting insulin (FINS). Twenty-nine articles (N = 3792) were included in the present meta-analysis. Intriguingly, vitamin D supplementation resulted in a vast improvement in FBG (standardized mean difference (SMD) = -0.38; 95%CI: -0.59, -0.16), HbA1c (SMD = -0.14; 95%CI: -0.22, -0.06) and FINS (SMD = 0.18; 95%CI: -0.26, -0.09), but not in other outcomes. However, preferred changes were observed in subgroups, as follows: Asia (SMD2h-PG = -0.25, 95%CI: -0.45, -0.04), study duration >= 1 year (SMDHOMA-IR = -0.44, 95%CI: -0.81, -0.06) (SMDHOMA-B = 0.34, 95%CI: 0.01, 0.66), baseline 25(OH)D < 50 nmol/L (SMD2h-PG = -0.23, 95%CI: -0.39, -0.06), and baseline 25(OH)D >= 50 nmol/L (SMDHOMA-IR = -0.50, 95%CI: -0.96, -0.03). In conclusion, oral supplementation of vitamin D has shown better effects in improving FBG, HbA1c, and FINS compared with controls among prediabetics; long-term vitamin D supplementation could have additional effects in participants with vitamin D deficiency for 2h-PG, HOMA-IR, and HOMA-B.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available